• ML385: NRF2 Inhibitor Workflows for Cancer and Stress Biolog

  2026-05-26

  ML385 is a selective NRF2 inhibitor trusted for dissecting oxidative stress and overcoming therapeutic resistance in cancer and liver disease models. This article delivers stepwise protocols, real troubleshooting advice, and actionable insights derived from the latest applied studies, including translational findings in ferroptosis and inflammation research.

• DiscoveryProbe Protease Inhibitor Library: Applied Workflows

  2026-05-26

  The DiscoveryProbe™ Protease Inhibitor Library empowers high-content and high-throughput screening with a rigorously validated, diverse set of 825 inhibitors. Explore how this library accelerates protease inhibition studies in cancer, apoptosis, and infectious disease research, with actionable workflow tips and troubleshooting insights.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-05-25

  Wang et al. reveal that the METTL16-SENP3-LTF signaling axis confers resistance to ferroptosis and accelerates tumorigenesis in hepatocellular carcinoma (HCC). Through mechanistic dissection, the study identifies METTL16 as a critical regulator of iron metabolism, suggesting new therapeutic strategies for sensitizing HCC to ferroptosis.

• 5-hme-dCTP: Epigenetic DNA Modification in Plant Stress Rese

  2026-05-25

  5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) is a high-purity, modified nucleotide enabling precise mapping and manipulation of DNA hydroxymethylation in plant epigenetic research. Its integration into advanced workflows supports discovery of 5-hmC’s regulatory roles in gene expression during environmental stress. The product’s ≥90% purity and solution stability make it a reliable substrate for rigorous DNA methylation dynamics studies.

• RBMS1 Loss Enables PD-L1 Blockade in Triple-Negative Breast

  2026-05-24

  The referenced study identifies RBMS1 as a post-transcriptional regulator of PD-L1 stability in triple-negative breast cancer (TNBC). By depleting RBMS1, the authors demonstrate enhanced anti-tumor immunity through destabilization of PD-L1, suggesting new avenues for improving checkpoint blockade therapies.

• LL-37 Peptides Combat MDR Acinetobacter baumannii: Mechanism

  2026-05-23

  This study demonstrates that the human antimicrobial peptide LL-37 and its fragments possess potent antimicrobial and antibiofilm activities against multidrug-resistant (MDR) Acinetobacter baumannii. The findings provide quantitative evidence for their rapid bactericidal effects and biofilm dispersal, advancing the search for novel agents against MDR hospital pathogens.

• Vardenafil HCl Trihydrate: Proteoform Context and Advanced A

  2026-05-22

  Explore Vardenafil HCl Trihydrate as a precision tool for dissecting PDE5 function within proteoform-specific membrane environments. This article uniquely connects top-down proteomics advances to practical assay strategies, offering new insights beyond conventional PDE5 inhibition research.

• Tetrandrine Alkaloid: Workflow Innovation for Ion Channel St

  2026-05-22

  Tetrandrine stands out as a high-purity, DMSO-soluble alkaloid for advanced ion channel modulation studies, offering robust reproducibility and workflow agility. This guide details experimental optimization, protocol enhancements, and troubleshooting strategies that make APExBIO’s Tetrandrine a leading choice for neuroscience, cancer biology, and anti-inflammatory research.

• Direct Mouse Genotyping Kit Plus: Precision in Myeloid Linea

  2026-05-21

  Explore how the Direct Mouse Genotyping Kit Plus streamlines high-fidelity mouse genotyping and advances myeloid lineage tracing. This in-depth analysis reveals unique assay strategies and practical insights beyond workflow optimization.

• Redefining Protease Inhibition: Strategic Leverage in Transl

  2026-05-21

  This thought-leadership article explores how a mechanistic understanding of protease inhibition, together with strategic compound library selection, accelerates translational discovery. It examines APExBIO's DiscoveryProbe™ Protease Inhibitor Library through the lens of contemporary challenges and opportunities in high throughput screening, bridging evidence from peer-reviewed literature and practical workflow guidance. The analysis provides a critical appraisal of current commercial offerings, practical protocol insights, and a forward-looking perspective on protease-targeted drug discovery.

• 4-Hydroxytamoxifen: Protocol Parameters and Lab Use Guidance

  2026-05-20

  4-Hydroxytamoxifen is a potent estrogen receptor modulator preferred for research workflows in breast and prostate cancer, as well as cardiac myocyte calcium handling studies. It should only be used in protocols compatible with DMSO-based solubilization and requires strict storage handling to maintain reagent quality.

• Disrupting SARS-CoV-2 N Protein Phase Separation: Mechanisti

  2026-05-20

  The referenced study uncovers how RNA-induced liquid–liquid phase separation (LLPS) of the SARS-CoV-2 nucleocapsid protein is essential for viral replication, and demonstrates that (-)-gallocatechin gallate (GCG) inhibits this process, reducing viral propagation. These findings provide a molecular rationale for targeting N protein phase behavior in antiviral strategy development.

• DR5 Agonist Antibodies Trigger PD-L1 Stabilization in Solid

  2026-05-19

  The referenced study uncovers a previously unrecognized mechanism by which DR5 agonist antibodies, designed to induce apoptosis in solid tumors, inadvertently stabilize PD-L1 and promote immune evasion. This finding suggests that targeting the DR5-ROCK1-PD-L1 axis could enhance immunotherapy outcomes in cancers such as TNBC and ovarian carcinoma.

• Imipramine in Autophagy and Apoptosis: Advanced Research Wor

  2026-05-19

  Imipramine, a tricyclic antidepressant, is redefining research into autophagy, apoptosis, and neuroimmunology through its potent molecular actions. This article unpacks optimized experimental workflows, protocol parameters, and troubleshooting approaches that leverage Imipramine’s unique profile, with direct translation from recent lipidomic and virology insights.

• Sulfo-NHS-LC-Biotin: Technical Guide for Cell Surface Labeli

  2026-05-18

  Sulfo-NHS-LC-Biotin is designed for covalent, water-based biotinylation of primary amines on proteins, particularly for selective labeling of cell surface proteins in biochemical assays. It should not be used for intracellular or reversible biotinylation due to its membrane-impermeable and irreversible chemistry.

597 records 10/40 page Previous Next First page 上5页 678910 下5页 Last page